Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Today Only! We’re helping you prep for your board exams
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
141 Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects Journal of Clinical Endocrinology and Metabolism, January 3, 2013 Clinical Article
142 Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene Sarcoma, January 3, 2013 Clinical Article
143 Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma Journal of Clinical Endocrinology and Metabolism, December 31, 2012
144 Nosocomial infections in leukemic and solid-tumor cancer patients: distribution, outcome and microbial spectrum of anaerobes Future Microbiology, December 26, 2012
145 p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction Cancer Research, December 19, 2012
146 Nrf2 expression is associated with poor outcome in osteosarcoma Pathology, December 19, 2012
147 TGF-β1 Signal is Crucial for De-Differentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma Stem Cells, December 14, 2012
148 Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases Anticancer Research, December 10, 2012
149 Low-grade Central Osteosarcoma of the Metatarsal Bone: A Clinicopathological, Immunohistochemical, Cytogenetic and Molecular Cytogenetic Analysis Anticancer Research, December 10, 2012
150 The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years Journal of Bone and Mineral Research, December 6, 2012 Clinical Article
151 Bone and soft tissue tumors of hip and pelvis European Journal of Radiology, December 6, 2012
152 Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma British Journal of Cancer, November 28, 2012
153 Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases Prostate Cancer & Prostatic Diseases, November 26, 2012
154 Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases--Equivalent efficacy, less toxicity, more convenient Cancer, November 26, 2012
155 Giant cell tumor of the tendon sheath mimicking a primary intramedullary metatarsal tumor Skeletal Radiology, November 20, 2012
156 Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma Clinical and Translational Oncology, November 15, 2012
157 Composite Reconstruction of the Hip Following Resection of Periacetabular Tumors: Middle-Term Outcome Journal of Arthroplasty, November 12, 2012
158 Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee European Journal of Surgical Oncology, November 12, 2012
159 Epiphysis preserving operations for the treatment of lower limb malignant bone tumors European Journal of Surgical Oncology, November 12, 2012
160 Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE Annals of Oncology, November 8, 2012
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summary1 18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma European Journal of Nuclear Medicine & Molecular Imaging, April 11, 2013
2 Preoperative and Therapeutic Embolization of Extremities of Bone and Soft Tissue Tumors Angiology, April 11, 2013
3 Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? European Journal of Cardio-Thoracic Surgery, April 5, 2013 Review Article
4 Incidence and relative survival of chordomas Cancer, April 4, 2013 Review Article
5 Osteosarcoma of the mobile spine Annals of Oncology, April 26, 2013
6 Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland British Journal of Cancer, April 5, 2013
7 Biological Reconstruction Following the Resection of Malignant Bone Tumors of the Pelvis Sarcoma, April 17, 2013
8 Do Malignant Bone Tumors of the Foot Have a Different Biological Behavior than Sarcomas at Other Skeletal Sites Sarcoma, April 1, 2013
9 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, April 29, 2013
10 MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma Human Pathology, April 11, 2013
11 Repiphysis prosthesis for limb preservation in pediatric patients with bone cancer: a literature review Orthopaedic Nursing, April 8, 2013 Review Article
12 Soft Tissue Chordomas: A Clinicopathologic Analysis of 11 Cases American Journal of Surgical Pathology , April 26, 2013
13 Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases Cancer, April 16, 2012 Free full text
14 Giant Cell Tumor of Bone: Review, Mimics, and New Developments in Treatment RadioGraphics, January 21, 2013 Review Article
15 Osseous Myxochondroid Sarcoma: A Detailed Study of 5 Cases of Extraskeletal Myxoid Chondrosarcoma of the Bone American Journal of Surgical Pathology , April 29, 2013
16 Satb2 is a novel marker of osteoblastic differentiation In bone and soft tissue tumors Histopathology, April 4, 2013
17 A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma Tumor Biology, April 18, 2013 Review Article
18 A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis European Journal of Cancer, April 29, 2013
19 The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models Clinical Cancer Research, April 12, 2013
20 Evaluation of Quercetin as a Potential Drug in Osteosarcoma Treatment Anticancer Research, April 11, 2013
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close